ICY:FRA
Incyte Corp
€101.15
arrow_upward
+1.64%(+1.63) 1D
Oct 8, 10:00:00 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ICY...
Open
€100.50
High
€101.15
Low
€98.16
Mkt. cap
22.85B
Avg. vol.
31.00
Volume
96.00
52-wk high
€115.40
52-wk low
€72.28
No. of employees
3K
Open
€100.50
High
€101.15
Low
€98.16
Mkt. cap
22.85B
Avg. vol.
31.00
Volume
96.00
52-wk high
€115.40
52-wk low
€72.28
No. of employees
3K
News stories
From web sources and news partners
Simply Wall Street
·
1 hour ago
Is Rare Disease Approval Altering The Investment Case For Incyte (INCY)?
BioSpace
·
15 hours ago
Incyte to Report Third Quarter 2026 Financial Results
MarketWatch
·
2 days ago
Incyte Corp. stock underperforms Tuesday when compared to competitors
Profile
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Incyte Corporation currently develops and manufactures prescription biopharmaceutical medications in multiple therapeutic areas including oncology, inflammation, and autoimmunity. Wikipedia
About Incyte Corp
CEO-
Employees2.84K
Founded2002
HeadquartersWilmington, Delaware, United States
SectorBiotechnology
Websiteincyte.com